Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia

Blood Cancer J. 2023 Jul 12;13(1):107. doi: 10.1038/s41408-023-00881-z.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Humans
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / therapy
  • Receptors, Chimeric Antigen* / genetics
  • T-Lymphocytes
  • Tissue Donors
  • Transplant Recipients

Substances

  • Receptors, Chimeric Antigen